Deep Dive: Deep Dive Into Biosynthesized Psychedelic Drugs

Dennis O'Neill discusses the treatment potential for biosynthesized psychedelic drugs for anxiety, depression, alcoholism, and terminal illness, and how BioMediCan is changing the game by sustainably and reliably synthesizing higher-quality psychedelics in large volumes.